The CEO of Elanco, Jeff Simmons, is highly bullish on the future of animal protein, citing a major consumer trend shifting away from plant-based alternatives due to failures in taste, cost, and nutrition.
Elanco is proactively addressing the environmental impact of livestock through innovation, such as a new product that reduces methane emissions from dairy cattle by approximately 50%, with the goal of creating climate-neutral farms.
The company is navigating geopolitical volatility with a pragmatic supply chain strategy, including an "Asia for Asia" model, while emphasizing that economic viability remains the primary driver of production decisions.
A $1 billion public-private partnership in Indiana, the "one health corridor," is being established by Elanco, Eli Lilly, and others to create an innovation hub designed to attract and retain top-tier scientific talent.
12 quotes
Concerns Raised
Slowing global population growth and lack of demand-side drivers in the economy.
The high-stakes, binary nature of innovation where failure to deliver a strong value proposition is costly.
Long-term sustainability of pension and healthcare systems in an aging society.
The climate impact of meat consumption remains a key challenge to the industry's reputation.
Opportunities Identified
The strong consumer shift back to animal protein from plant-based alternatives.
The growing 'humanization of pets' trend, driving increased spending on pet health.
Developing and marketing technologies that create climate-neutral and sustainable farming.
Continued growth in Asian markets, particularly in the ASEAN region.